TGF-β1 acts through miR-155 to down-regulate TP53INP1 in promoting epithelial-mesenchymal transition and cancer stem cell phenotypes

Cancer Letters

Volumn 359, Issue 2, 2015, Pages 288-298

  Liu, Fengchao ^a   Kong, Xin ^a   Lv, Lin ^a   Gao, Jian ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Cancer stem cell; Epithelial mesenchymal transition; MiR 155; TP53INP1; Tumour sphere

Indexed keywords

CD133 ANTIGEN; MICRORNA 155; NUCLEAR PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; PROTEIN TP53INP1; THY 1 ANTIGEN; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; CARRIER PROTEIN; HEAT SHOCK PROTEIN; MICRORNA; MIRN155 MICRORNA, HUMAN; TGFB1 PROTEIN, HUMAN; TP53INP1 PROTEIN, HUMAN;

ANTIGEN EXPRESSION; ARTICLE; CANCER STEM CELL; CELL INVASION; CELL MOTILITY; CELL TRANSFORMATION; CONTROLLED STUDY; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE OVEREXPRESSION; GENE SILENCING; HEPG2 CELL LINE; HUMAN; HUMAN CELL; LIVER CANCER; LIVER CARCINOGENESIS; ONCOLOGICAL PARAMETERS; PHENOTYPE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR SPHERE; UPREGULATION; GENE EXPRESSION; GENETICS; LIVER TUMOR; METABOLISM; PHYSIOLOGY; RNA INTERFERENCE;

CARRIER PROTEINS; EPITHELIAL-MESENCHYMAL TRANSITION; GENE EXPRESSION; HEAT-SHOCK PROTEINS; HEP G2 CELLS; HUMANS; LIVER NEOPLASMS; MICRORNAS; NEOPLASTIC STEM CELLS; PHENOTYPE; RNA INTERFERENCE; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84923078124     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2015.01.030     Document Type: Article

References (52)

1. Jemal A., Bray F., Center M.M., Ferlay J., Ward E., Forman D. Global cancer statistics. CA Cancer J. Clin 2011, 61:69-90.
2. Gupta G.P., Massague J. Cancer metastasis: building a framework. Cell 2006, 127:679-695.
3. Fidler I.J. The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat. Rev. Cancer 2003, 3:453-458.
4. Nguyen D.X., Bos P.D., Massague J. Metastasis: from dissemination to organ-specific colonization. Nat. Rev. Cancer 2009, 9:274-284.
5. Polyak K., Weinberg R.A. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat. Rev. Cancer 2009, 9:265-273.
6. Yao R., Jiang H., Ma Y., Wang L., Wang L., Du J., et al. PRMT7 induces epithelial-to-mesenchymal transition and promotes metastasis in breast cancer. Cancer Res 2014, 74:5656-5667.
7. Jing Y., Cui D., Guo W., Jiang J., Jiang B., Lu Y., et al. Activated androgen receptor promotes bladder cancer metastasis via Slug mediated epithelial-mesenchymal transition. Cancer Lett 2014, 348:135-145.
8. Ding Q., Miyazaki Y., Tsukasa K., Matsubara S., Yoshimitsu M., Takao S. CD133 facilitates epithelial-mesenchymal transition through interaction with the ERK pathway in pancreatic cancer metastasis. Mol. Cancer 2014, 13:15.
9. Reichl P., Haider C., Grubinger M., Mikulits W. TGF-beta in epithelial to mesenchymal transition and metastasis of liver carcinoma. Curr. Pharm. Des 2012, 18:4135-4147.
10. Thiery J.P., Acloque H., Huang R.Y., Nieto M.A. Epithelial-mesenchymal transitions in development and disease. Cell 2009, 139:871-890.
11. Gavert N., Ben-Ze'ev A. Epithelial-mesenchymal transition and the invasive potential of tumors. Trends Mol. Med 2008, 14:199-209.
12. Jordan C.T., Guzman M.L., Noble M. Cancer stem cells. N. Engl. J. Med 2006, 355:1253-1261.
13. Shiozawa Y., Nie B., Pienta K.J., Morgan T.M., Taichman R.S. Cancer stem cells and their role in metastasis. Pharmacol. Ther 2013, 138:285-293.
14. Visvader J.E., Lindeman G.J. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat. Rev. Cancer 2008, 8:755-768.
15. Yang Z.F., Ho D.W., Ng M.N., Lau C.K., Yu W.C., Ngai P., et al. Significance of CD90+ cancer stem cells in human liver cancer. Cancer Cell 2008, 13:153-166.
16. Ma S., Tang K.H., Chan Y.P., Lee T.K., Kwan P.S., Castilho A., et al. MiR-130b promotes CD133(+) liver tumor-initiating cell growth and self-renewal via tumor protein 53-induced nuclear protein 1. Cell Stem Cell 2010, 7:694-707.
17. Yamashita T., Honda M., Nakamoto Y., Baba M., Nio K., Hara Y., et al. Discrete nature of EpCAM+ and CD90+ cancer stem cells in human hepatocellular carcinoma. Hepatology 2013, 57:1484-1497.
18. Kabashima A., Higuchi H., Takaishi H., Matsuzaki Y., Suzuki S., Izumiya M., et al. Side population of pancreatic cancer cells predominates in TGF-beta-mediated epithelial to mesenchymal transition and invasion. Int. J. Cancer 2009, 124:2771-2779.
19. Cao L., Zhou Y., Zhai B., Liao J., Xu W., Zhang R., et al. Sphere-forming cell subpopulations with cancer stem cell properties in human hepatoma cell lines. BMC Gastroenterol 2011, 11:71.
20. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
21. Chen C.Z. MicroRNAs as oncogenes and tumor suppressors. N. Engl. J. Med 2005, 353:1768-1771.
22. Callegari E., Gramantieri L., Domenicali M., Abundo L.D., Sabbioni S., Negrini M. MicroRNAs in liver cancer: a model for investigating pathogenesis and novel therapeutic approaches. Cell Death Differ 2015, 22:46-57.
23. Ceppi P., Peter M.E. MicroRNAs regulate both epithelial-to-mesenchymal transition and cancer stem cells. Oncogene 2014, 33:269-278.
24. Ji J., Yamashita T., Budhu A., Forgues M., Jia H.L., Li C., et al. Identification of microRNA-181 by genome-wide screening as a critical player in EpCAM-positive hepatic cancer stem cells. Hepatology 2009, 50:472-480.
25. Kong W., Yang H., He L., Zhao J.J., Coppola D., Dalton W.S., et al. MicroRNA-155 is regulated by the transforming growth factor beta/Smad pathway and contributes to epithelial cell plasticity by targeting RhoA. Mol. Cell. Biol 2008, 28:6773-6784.
26. Qin W., Ren Q., Liu T., Huang Y., Wang J. MicroRNA-155 is a novel suppressor of ovarian cancer-initiating cells that targets CLDN1. FEBS Lett 2013, 587:1434-1439.
27. Tian J., Tang Z.Y., Ye S.L., Liu Y.K., Lin Z.Y., Chen J., et al. New human hepatocellular carcinoma (HCC) cell line with highly metastatic potential (MHCC97) and its expressions of the factors associated with metastasis. Br. J. Cancer 1999, 81:814-821.
28. Li Y., Tang Y., Ye L., Liu B., Liu K., Chen J., et al. Establishment of a hepatocellular carcinoma cell line with unique metastatic characteristics through in vivo selection and screening for metastasis-related genes through cDNA microarray. J. Cancer Res. Clin. Oncol 2003, 129:43-51.
29. Hsieh I.S., Chang K.C., Tsai Y.T., Ke J.Y., Lu P.J., Lee K.H., et al. MicroRNA-320 suppresses the stem cell-like characteristics of prostate cancer cells by downregulating the Wnt/beta-catenin signaling pathway. Carcinogenesis 2013, 34:530-538.
30. Xia H., Cheung W.K., Ng S.S., Jiang X., Jiang S., Sze J., et al. Loss of brain-enriched miR-124 microRNA enhances stem-like traits and invasiveness of glioma cells. J. Biol. Chem 2012, 287:9962-9971.
31. Dontu G., Abdallah W.M., Foley J.M., Jackson K.W., Clarke M.F., Kawamura M.J., et al. In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev 2003, 17:1253-1270.
32. Tu Y., Gao X., Li G., Fu H., Cui D., Liu H., et al. MicroRNA-218 inhibits glioma invasion, migration, proliferation, and cancer stem-like cell self-renewal by targeting the polycomb group gene Bmi1. Cancer Res 2013, 73:6046-6055.
33. Jia Q., Zhang X., Deng T., Gao J. Positive correlation of Oct4 and ABCG2 to chemotherapeutic resistance in CD90(+)CD133(+) liver cancer stem cells. Cell Reprogram 2013, 15:143-150.
34. Tang J., Tao Z.H., Wen D., Wan J.L., Liu D.L., Zhang S., et al. MiR-612 suppresses the stemness of liver cancer via Wnt/beta-catenin signalling. Biochem. Biophys. Res. Commun 2014, 447:210-215.
35. Ghods A.J., Irvin D., Liu G., Yuan X., Abdulkadir I.R., Tunici P., et al. Spheres isolated from 9L gliosarcoma rat cell line possess chemoresistant and aggressive cancer stem-like cells. Stem Cells 2007, 25:1645-1653.
36. Mani S.A., Guo W., Liao M.J., Eaton E.N., Ayyanan A., Zhou A.Y., et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008, 133:704-715.
37. Xiang X., Zhuang X., Ju S., Zhang S., Jiang H., Mu J., et al. miR-155 promotes macroscopic tumor formation yet inhibits tumor dissemination from mammary fat pads to the lung by preventing EMT. Oncogene 2011, 30:3440-3453.
38. Gironella M., Seux M., Xie M.J., Cano C., Tomasini R., Gommeaux J., et al. Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:16170-16175.
39. Zhang C., Zhao J., Deng H. 17beta-estradiol up-regulates miR-155 expression and reduces TP53INP1 expression in MCF-7 breast cancer cells. Mol. Cell. Biochem 2013, 379:201-211.
40. Yang G., Quan Y., Wang W., Fu Q., Wu J., Mei T., et al. Dynamic equilibrium between cancer stem cells and non-stem cancer cells in human SW620 and MCF-7 cancer cell populations. Br. J. Cancer 2012, 106:1512-1519.
41. Shuang Z.Y., Wu W.C., Xu J., Lin G., Liu Y.C., Lao X.M., et al. Transforming growth factor-beta1-induced epithelial-mesenchymal transition generates ALDH-positive cells with stem cell properties in cholangiocarcinoma. Cancer Lett 2014, 354:320-328.
42. Massague J. TGFbeta in cancer. Cell 2008, 134:215-230.
43. Malanchi I., Santamaria-Martinez A., Susanto E., Peng H., Lehr H.A., Delaloye J.F., et al. Interactions between cancer stem cells and their niche govern metastatic colonization. Nature 2012, 481:85-89.
44. Fan X., Chen X., Deng W., Zhong G., Cai Q., Lin T. Up-regulated microRNA-143 in cancer stem cells differentiation promotes prostate cancer cells metastasis by modulating FNDC3B expression. BMC Cancer 2013, 13:61.
45. Han M., Wang Y., Liu M., Bi X., Bao J., Zeng N., et al. MiR-21 regulates epithelial-mesenchymal transition phenotype and hypoxia-inducible factor-1alpha expression in third-sphere forming breast cancer stem cell-like cells. Cancer Sci 2012, 103:1058-1064.
46. Johansson J., Berg T., Kurzejamska E., Pang M.F., Tabor V., Jansson M., et al. MiR-155-mediated loss of C/EBPbeta shifts the TGF-beta response from growth inhibition to epithelial-mesenchymal transition, invasion and metastasis in breast cancer. Oncogene 2013, 32:5614-5624.
47. Seux M., Peuget S., Montero M.P., Siret C., Rigot V., Clerc P., et al. TP53INP1 decreases pancreatic cancer cell migration by regulating SPARC expression. Oncogene 2011, 30:3049-3061.
48. Heldin C.H., Landstrom M., Moustakas A. Mechanism of TGF-beta signaling to growth arrest, apoptosis, and epithelial-mesenchymal transition. Curr. Opin. Cell Biol 2009, 21:166-176.
49. Xu Q., Sun Q., Zhang J., Yu J., Chen W., Zhang Z. Downregulation of miR-153 contributes to epithelial-mesenchymal transition and tumor metastasis in human epithelial cancer. Carcinogenesis 2013, 34:539-549.
50. Villar V., Kocic J., Santibanez J.F. Spred2 inhibits TGF-beta1-induced urokinase type plasminogen activator expression, cell motility and epithelial mesenchymal transition. Int. J. Cancer 2010, 127:77-85.
51. Pirozzi G., Tirino V., Camerlingo R., Franco R., La Rocca A., Liguori E., et al. Epithelial to mesenchymal transition by TGFbeta-1 induction increases stemness characteristics in primary non small cell lung cancer cell line. PLoS ONE 2011, 6:e21548.
52. Fan Q.M., Jing Y.Y., Yu G.F., Kou X.R., Ye F., Gao L., et al. Tumor-associated macrophages promote cancer stem cell-like properties via transforming growth factor-beta1-induced epithelial-mesenchymal transition in hepatocellular carcinoma. Cancer Lett 2014, 352:160-168.